====== COVID-19 Vaccine Batch Analysis ======
The variability of quality, including efficacy and adverse events data, of vaccine batches and lots has been controversial during the mass experimental [[:quasi-vaccine]] program.

See also,
  * [[covid-19_vaccines:safety_of_covid-19_vaccines|COVID-19 Vaccine Safety]]

===== Batch/Lot Analysis =====
There is substantial debate over a "hot lots" hypothesis that particular batches or lots of COVID-19 vaccines are substantially more toxic than others. Some researchers such as former [[:pharmaceutical_companies:pfizer|Pfizer]] Chief Scientist [[:Michael Yeadon]] think that there may be bad batches or lots of vaccines, and that this might even be intentional.((February 3, 2022 | [[:Michael Yeadon]] | [[https://rumble.com/vtxiry-dr-mike-yeadon-calibration-of-a-killing-weapon.html|Dr Mike Yeadon Calibration Of a Killing Weapon]])) Others such as [[:Jessica Rose]] and [[:Mathew Crawford]] think that there are reasonable explanations for the varied data.((December 1, 2022 | [[:Jessica Rose]] | [[https://jessicar.substack.com/p/is-someone-staggering-the-more-toxic|Is someone staggering the more 'toxic' Vax Lots?]]))((February 7, 2022 | [[:Mathew Crawford]] | [[:Rounding The Earth]] | [[https://roundingtheearth.substack.com/p/understanding-batch-lot-toxicity|Understanding Batch Lot Toxicity]]))

In August 2021, Japan rejected 1.6 million doses of [[:pharmaceutical_companies:moderna|Moderna]]'s vaccine due to contamination with particulate matter, including what seemed like magnetic metals.((August 26, 2021 | Nikkei Asia | [[https://asia.nikkei.com/Spotlight/Coronavirus/COVID-vaccines/1.6m-Moderna-doses-withdrawn-in-Japan-over-contamination|1.6m Moderna doses withdrawn in Japan over contamination]]))

  * [[https://howbadismybatch.com/|How Bad is My Batch]] is Craig Paardakooper's project studying relationships between batch codes/lots and adverse events.
  * [[https://howbad.info/index.html|HowBad.info]]

===== Preferential Batches for Insiders =====
There are distinct commercial and clinical processes for producing vaccines as outlined on page 18 in an assessment report by the [[:European Medicines Agency]] on Pfizer's [[:Comirnaty]] vaccine.((February 19, 2021 | [[:European Medicines Agency]] | Committee for Medicinal Products for Human Use (CHMP) | [[https://www.ema.europa.eu/en/documents/assessment-report/comirnaty-epar-public-assessment-report_en.pdf|Comirnaty Assessment Report]])) Controversially, the superior (clinical) quality vaccines with better testing data were preferentially set aside for Pfizer employees.((December 2021 | [[:The Hotstar]] | [[http://thehotstar.net/separatebatches.html|Pfizer allocates separate vaccine batches to its employees and corporate partners]])) The Therapeutic Goods Administration in [[:Australia]] outlines such a preferential program with purity and integrity assessments for vaccine batches.((Therapeutic Goods Administration of Australia | [[https://www.tga.gov.au/batch-release-assessment-covid-19-vaccines|Batch Release Assessment for COVID-19 Vaccines]])) Vaccine safety researcher [[:Jessica Rose]] points out that there are no VAERS reports for any of the batches listed by the Australian government.((January 25, 2022 | [[:Jessica Rose]] | [[https://jessicar.substack.com/p/special-aussie-batches-made-just|Limited batch quantity allocated for use in Pfizer Australia employee vaccination program]]))